* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : mastology;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://www.inspq.qc.ca/publications/3627
2025
Canada
technical report
Program
Portrait
portraits as topic
screening for cancer
mammography, nos
breast cancer
cancer screening
early detection of cancer
breast neoplasms
mammography

---
https://ansm.sante.fr/tableau-marr/alpelisib
2025
false
false
false
France
French
guidelines for drug use
administration, oral
Drug-Related side effects and adverse reactions
alpelisib
Alpelisib
Alpelisib
continuity of patient care
Hyperglycaemic hyperosmolar nonketotic syndrome
hyperglycemia
ketosis
thiazoles
thiazoles

---
https://beh.santepubliquefrance.fr/beh/2025/5/2025_5_1.html
2025
France
journal article
population groups
france
salmonella typhimurium
mother, nos
breast
salmonella typhimurium
schools, nursery
french
snacks
mars

---
https://www.ema.europa.eu/en/medicines/human/EPAR/apexelsin
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
paclitaxel
paclitaxel

---
https://minerva-ebp.be/FR/Article/2430
2025
Belgium
critical appraisal or critical reading
screening for cancer
cancer screening
breast cancer
patients
breast neoplasms
early detection of cancer
has patient

---
https://www.has-sante.fr/jcms/p_3601434/fr/verzenios-abemaciclib-cancer-du-sein
2025
false
false
false
France
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
menopause
evaluation of the transparency committee
abemaciclib
breast neoplasms
abemaciclib
breast cancer
Verzenio
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3601428/fr/kisqali-ribociclib-cancer-du-sein
2025
false
false
false
France
treatment outcome
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
evaluation of the transparency committee
neoplasm, malignant
Kisqali
breast cancer
ribociclib
breast neoplasms
ribociclib

---
https://ansm.sante.fr/informations-de-securite/kisqali-ribociclib-changement-des-conditions-de-conservation-et-de-la-duree-de-conservation
2025
false
false
false
France
French
drug information
guideline
drug storage
ribociclib

---
https://ansm.sante.fr/tableau-acces-derogatoire/avastin-r-25-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
Bevacizumab
drug information
guidelines for drug use
intravitreal injections
macular degeneration
Neovascular age-related macular degeneration

---
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet

---
https://www.has-sante.fr/jcms/p_3577228/fr/cancer-sein-colorectal-prostate-l-activite-physique-pour-votre-sante
2025
France
patient education handout
paper
prostate cancer
prostate, nos
neoplasm, malignant
Colorectal Cancer
physics
exercise
breast neoplasms
prostatism, nos
malignant neoplasm colon/rectum
malignant neoplasm prostate
health
prostatic neoplasms
breast cancer
colorectal neoplasms

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/algorithmes-dinvestigation-de-traitement-et-de-suivi-du-cancer-du-sein.html
2025
Canada
algorithms
algorithms
research personnel
breast neoplasms
neoplasm, malignant
breast cancer
aftercare

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_3.html
2025
France
journal article
cancer screening
breast neoplasms
mass screening
due to
screening for cancer
early detection of cancer
organization
french
Program
france
breast cancer

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-marie-guyomard
2025
France
audiovisual aids
nursing
attention
critical pathways
neoplasm, malignant
dataset
evaluation studies as topic
breast cancer
qualitative evaluation
protestantism
breast neoplasms

---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
Metastatic Gastric Adenocarcinoma
stomach neoplasms
adenocarcinoma
neoplasm metastasis
Locally Advanced Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
HER2/Neu Positive
trastuzumab deruxtecan
infusions, intravenous
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
Metastatic HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm recurrence, local

---
https://www.has-sante.fr/jcms/p_3598458/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2-faible-ou-ultra-faible
2025
false
false
false
France
evaluation of the transparency committee
breast neoplasms
Trastuzumab
trastuzumab deruxtecan
trastuzumab

---
https://www.has-sante.fr/jcms/p_3471037/fr/
2024
France
health technology assessment
genome, nos
Early Stage Breast Carcinoma
breast cancer
Useful
hospitals, proprietary
Clinical Data
Signature
Genome
early
Clinical Lot
breast neoplasms
Ambulatory Care Facility
neoplasm staging
genomics
Clinical Batch
genome
neoplasm, malignant

---
http://publications.msss.gouv.qc.ca/msss/document-000288/
2024
false
false
false
Canada
patient education handout
screening for cancer
Program
breast neoplasms
Breast cancer
breast cancer
cancer screening
early detection of cancer

---
https://www.has-sante.fr/jcms/p_3490834/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
sacituzumab govitecan
HER2/Neu Negative
Hormone Receptor Positive
evaluation of the transparency committee
breast neoplasms
sacituzumab govitecan

---
https://publications.msss.gouv.qc.ca/msss/document-003690/
2024
Canada
handbooks
Guide Device
Medical Examination
Radiation Boost
complement system proteins
symptom assessment
Handbook
Digital Mammography
mammography, nos
mammography
CDISC SDTM Medical Evaluator Identifier Terminology

---
https://www.has-sante.fr/jcms/p_3494990/fr/orserdu-elacestrant-cancer-du-sein
2024
false
false
false
France
elacestrant
insurance, health, reimbursement
treatment outcome
postmenopause
Activating ESR1 Gene Mutation
Locally Advanced Estrogen Receptor-Positive Breast Carcinoma
Metastatic Estrogen Receptor-Positive Breast Carcinoma
HER2/Neu Negative
administration, oral
selective estrogen receptor modulators
evaluation of the transparency committee
elacestrant
breast neoplasms

---
https://www.has-sante.fr/jcms/p_3497062/fr/iomeron-iomeprol-produit-de-contraste-iode
2024
false
false
false
France
evaluation of the transparency committee
iodine, nos
iomeprol
contrast media
iomeprol
Iomeprol
iomeron
iomeprol
iodine

---
https://www.has-sante.fr/jcms/p_3498750/fr/keytruda-pembrolizumab-carcinome-a-cellules-renales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
clear cell renal cell carcinoma
Lenvatinib/Pembrolizumab Regimen
Advanced Clear Cell Renal Cell Carcinoma
infusions, intravenous
Antineoplastic Agents, Immunological
pembrolizumab
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://www.ema.europa.eu/en/medicines/human/EPAR/orserdu
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
elacestrant
elacestrant
elacestrant
postmenopause
drug approval
europe
selective estrogen receptor modulators
selective estrogen receptor modulators
breast neoplasms
breast neoplasms, male
Locally Advanced Estrogen Receptor-Positive Breast Carcinoma
Metastatic Estrogen Receptor-Positive Breast Carcinoma
HER2-Negative Breast Carcinoma
administration, oral
risk management
product surveillance, postmarketing
drug interactions
Activating ESR1 Gene Mutation
breast neoplasms
estrogen receptor alpha
drug evaluation, preclinical

---
https://www.cancer.fr/catalogue-des-publications/traitements-systemiques-des-cancers-du-sein-localises-de-sous-type-histologique-re-her2-question-clinique-1-chimiotherapie-neoadjuvante-ind
https://www.cancer.fr/catalogue-des-publications/traitements-systemiques-des-cancers-du-sein-localises-cancers-de-sous-type-histologique-re-her2-thesaurus
2024
false
false
false
France
practice guideline
Treating
Treatment Study
Tray Dosing Unit
Treat
Female Breast
Systemic Immunotherapy
During Treatment
Localized
GDC Treatment Frequency Terminology
NCI Thesaurus
Treatment Epoch
vocabulary, controlled
Therapy Object
Histologic Type
Device System
Drug Delivery System
thesaurus
Thesaurus
Locally
No Treatment for Diabetes
Trait
On Treatment
Tray
Male Breast
Murine Breast
Drug Delivery System Category
Treatment
histology
breast
Biomaterial Treatment

---
https://www.cancer.fr/catalogue-des-publications/traitements-systemiques-des-cancers-du-sein-localises-de-sous-type-histologique-triple-negatif-3-questions-cliniques
2024
false
false
false
France
practice guideline
No Treatment for Diabetes
SDHB Negative
triplets
Drug Delivery System
Device System
Hepatitis B Surface Antibody Negative
Localized
10q23/PTEN Locus Deletion Negative
Have Not Tried It
thesaurus
ETV Gene Rearrangement Negative
FGFR2 Gene Rearrangement Negative
PAS Negative
TERT Promoter Mutation Negative
Tray Dosing Unit
Systemic Immunotherapy
Thesaurus
Hepatitis B Virus Surface Antigen Negative
Lack of Expression of PD-L1
CDH1 Gene Mutation Negative
Treat
Treating
BAP1 Gene Mutation Negative
FGFR3 Gene Mutation Negative
Treatment Study
IDH Family Wildtype
breast
Locally
Drug Delivery System Category
PAX8 Gene Rearrangement Negative
On Treatment
CDKN2A-p16 Negative
HRAS Gene Mutation Negative
RET Gene Rearrangement Negative
Epstein-Barr Virus Negative
GNA11 Gene Mutation Negative
ESR2 Negative
Male Breast
vocabulary, controlled
GNAQ Gene Mutation Negative
Polypodium leucotomos Extract
During Treatment
ERG Gene Rearrangement Negative
Murine Breast
NCI Thesaurus
Therapy Object
Trait
Treatment
NRAS Gene Mutation Negative
Female Breast
Negative Number
Unmethylated MGMT Gene Promoter
ANO1 Negative
ATRX Gene Mutation Negative
BRAF Gene Mutation Negative
KIT Negative
Histologic Type
KRAS Gene Mutation Negative
Biomaterial Treatment
Human Immunodeficiency Virus Negative
Treatment Epoch
SDHA Negative
Tray
ERBB2 Gene Amplification Negative
GDC Treatment Frequency Terminology
FGFR2 Gene Mutation Negative
FGFR1 Gene Mutation Negative
Wnt Negative
Negative Charge
CTNNB1 Gene Mutation Negative
Hepatitis B Virus Core Antibody Negative
ERBB2 Gene Mutation Negative
histology
Negative Lymph Node
Progesterone Receptor Negative
FGFR3 Gene Rearrangement Negative

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024003/article/00002-fra.htm
2024
Canada
technical report
Female Breast
Care Of
Murine Breast
specialization
Access to Care
Health Care Delivery
Older Population
health services accessibility
Population Health
breast
Specialized
specialism
Male Breast
health services
health care
State or Local Health Department

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-11-03-2024-sur-le-medicament-keytruda-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
treatment outcome
pembrolizumab
Antineoplastic Agents, Immunological
drug information
Resectable Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
neoplasm recurrence, local
risk
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3512093/fr/talzenna-talazoparib-cancer-de-la-prostate
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Enzalutamide/Talazoparib Regimen
enzalutamide
metastatic castration resistant prostate cancer
adult
neoplasm metastasis
administration, oral
talazoparib
Poly(ADP-ribose) Polymerase Inhibitors
Product containing only talazoparib in oral dose form (medicinal product form)
evaluation of the transparency committee
talazoparib
prostatic neoplasms, Castration-Resistant

---
https://www.has-sante.fr/jcms/p_3517160/fr/tecentriq-atezolizumab-oncologie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only atezolizumab in parenteral dose form (medicinal product form)
atezolizumab
antineoplastic combined chemotherapy protocols
Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen
neoplasm metastasis
carcinoma, non-small-cell lung
small cell lung carcinoma
Extensive Stage Lung Small Cell Carcinoma
antineoplastic agents
Unresectable Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
carcinoma, hepatocellular
evaluation of the transparency committee
atezolizumab

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-du-cancer-du-sein-par-tomosynthese-mammaire.html
2024
Canada
public health guidelines
Mammary
breast cancer
Breast Cancer Screening
screening for cancer
Murine Mammary Gland
cancer screening
early detection of cancer
breast, nos
breast neoplasms

---
https://www.rheuma-net.ch/fr/doc/cyclophosphamid-1/viewdocument/348
2024
Switzerland
guideline
cyclophosphamide
cyclophosphamide
Background Treatment
Cyclophosphamide

---
https://canadiantaskforce.ca/lignesdirectrives/lignes-directrices-publiees/cancer-du-sein-mise-a-jour-2024/?lang=fr
2024
Canada
practice guideline
breast cancer
Software Maintenance
CDISC Provisional Standard
breast neoplasms
Childhood Breast Carcinoma
Interim
Update
Male Breast Carcinoma
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3519904/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2024
false
false
false
France
antineoplastic combined chemotherapy protocols
endometrial neoplasms
evaluation of the transparency committee
durvalumab
olaparib

---
https://www.cochrane.org/fr/CD013822/BREASTCA_la-prise-de-decision-partagee-aide-t-elle-les-femmes-decider-de-participer-ou-non-au-depistage-du
2024
United Kingdom
review of literature
french abstract
Made Right Decision
Breast Cancer Screening
breast cancer
early detection of cancer
cancer screening
breast neoplasms
Share
Undecided
screening for cancer
What Month is it
Decision Making, Shared
women
Subject Decision
Woman
Shared
operations research
Participation
Decision Aid

---
https://www.ema.europa.eu/en/medicines/human/EPAR/naveruclif
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
paclitaxel
paclitaxel
drugs, generic

---
https://www.cochrane.org/fr/CD016043/EYES_de-quelle-maniere-les-examens-de-la-vue-et-les-lunettes-sont-ils-fournis-au-sein-de-la-communaute-et
2024
United Kingdom
review of literature
french abstract
eye glasses
Global Health
Health Center
What Month is it
examination of breast, nos
breast
Male Breast
Medical Examination
mannerism
Female Breast
residence characteristics
world health
Examination
Chronic Villitis
Provide
Glasses
Murine Breast
eye protective devices
goggles
health facilities
Review
central
community
Sight
vision, ocular

---
https://www.has-sante.fr/jcms/p_3527216/fr/afinitor-everolimus-tumeurs-neuroendocrines-d-origine-pancreatique
2024
false
false
false
France
pancreatic neoplasms
treatment outcome
insurance, health, reimbursement
disease progression
adult
Metastatic Pancreatic Neuroendocrine Tumor
Unresectable Pancreatic Neuroendocrine Tumor
administration, oral
antineoplastic agents
everolimus
evaluation of the transparency committee
neuroendocrine tumors
Everolimus

---
https://www.rp2s.fr/wp-content/uploads/2024_Protocole_transfert_pour_embolisation.pdf
2024
France
guideline
Transfer Ability
Embolization Therapy
Murine Breast
Female Breast
Maternal Relative
Male Breast
Transference
Transfer
mother, nos
Countertransference
Transfer, Psychology
breast
Maternal

---
https://www.has-sante.fr/jcms/p_3527474/fr/orserdu-elacestrant-cancer-du-sein
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
estrogen receptor positive breast cancer
Locally Advanced Estrogen Receptor-Positive Breast Carcinoma
breast neoplasms, male
Metastatic Estrogen Receptor-Positive Breast Carcinoma
administration, oral
elacestrant
postmenopause
selective estrogen receptor modulators
evaluation of the transparency committee
breast neoplasms
Male Breast Carcinoma
elacestrant

---
https://www.sfed.org/wp-content/uploads/2024/07/RecoSFED-GIFE-personnelparamedical-au-sein-dun-plateau-technique-endo-digestive-24.pdf
2024
France
guideline
digestive tract function, nos
breast
Tray
endoscopy, digestive system
health planning guidelines
Female Breast
Digestion
paramedics
Paramedic
Endoscopic Procedure
allied health personnel
endoscopy of breast, nos
digestant, nos
Male Breast
Murine Breast

---
https://dumas.ccsd.cnrs.fr/dumas-04594556
2024
France
dissertations, academic
Mammary
insight, nos
Murine Mammary Gland
Splayed
knowledge
breast, nos
Woman
acquaintance
breast self-examination
women

---
https://www.has-sante.fr/jcms/p_3530407/fr/cyclophosphamide-accord-cyclophosphamide-cancer-et-maladies-auto-immunes
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only cyclophosphamide in parenteral dose form (medicinal product form)
precursor cell lymphoblastic Leukemia-Lymphoma
cyclophosphamide
transplantation conditioning
multiple myeloma
hodgkin disease
lymphoma, Non-Hodgkin
ovarian neoplasms
breast neoplasms
neoplasm metastasis
sarcoma, ewing
small cell lung carcinoma
bronchial neoplasms
neuroblastoma
lupus nephritis
Granulomatosis with Polyangiitis
myeloablative agonists
antineoplastic agents, alkylating
immunosuppressive agents
evaluation of the transparency committee
cyclophosphamide
autoimmune diseases

---
https://www.has-sante.fr/jcms/p_3530992/fr/enhertu-trastuzumab-deruxtecan-cancer-du-poumon
2024
false
false
false
France
evaluation of the transparency committee
Lung Carcinoma
neoplasm, malignant
Trastuzumab Deruxtecan
lung neoplasms
Trastuzumab Deruxtecan
trastuzumab deruxtecan
lung cancer
trastuzumab
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3534500/fr/mentor
2024
France
health technology assessment
Smooth
Selective Estrogen Receptor Modulator
Round Cell Count
Sadness
Serum Sample
mentors
RWDD3 wt Allele
physiology
PHGDH wt Allele
breast implants
round shape
serum
serum
Round
Serum
Reversible Posterior Leukoencephalopathy Syndrome
physiologist
Breast Implant
breast, nos
implant, nos
Fill

---
https://www.has-sante.fr/jcms/p_3420797/fr/keytruda-pembrolizumab-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
breast neoplasms
pembrolizumab
breast cancer
pembrolizumab
Childhood Breast Carcinoma
Pembrolizumab
neoplasm, malignant
Male Breast Carcinoma
Keytruda
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3537214/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
neoplasm, malignant
Sacituzumab Govitecan
Male Breast Carcinoma
sacituzumab govitecan
breast neoplasms
breast cancer
sacituzumab govitecan
Childhood Breast Carcinoma

---
https://www.cochrane.org/fr/CD013451/BREASTCA_les-inhibiteurs-de-la-resorption-osseuse-contribuent-ils-reduire-la-perte-osseuse-chez-les-femmes
2024
United Kingdom
review of literature
french abstract
Bone Resorption Inhibitor
neoplasm, malignant
female mammary gland
Localized Malignant Neoplasm
bone resorption inhibitor, nos
neoplasm staging
women
antiresorptive agents
bone density conservation agents
breast neoplasms
disease
Early Stage Breast Carcinoma
What Month is it
malignant neoplasm breast female
Osteopenia
early
breast cancer
Locally Advanced Malignant Neoplasm
Female Breast Carcinoma
Locally Advanced Disease Clinical Trial Setting
bone neoplasms

---
https://www.asn.fr/l-asn-informe/actualites/mammographie-recommandations-du-gprp-et-prise-de-position-de-l-asn
2024
France
guideline
CDISC SDTM Body Position Terminology
GPX2 wt Allele
Position
mammography
health planning guidelines
Gene Physical Location
Asparagine Measurement
Mammography
Asparagine
mammography, nos

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1388
2024
France
public health guidelines
west nile virus
paris
has assessment
dengue virus
Set, Psychology
evaluation studies as topic
device, nos
devices
simian immunodeficiency virus
french
play and playthings
france
blood
dengue virus, nos
bone screws
breast

---
https://www.cancer.fr/presse/des-50-ans-faites-vous-depister-tous-les-2-ans-vous-vous-en-remercierez-l-institut-national-du-cancer-invite-les-femmes-a-realiser-le-depista
2024
false
false
false
France
popular works
screening for cancer
institutes
breast cancer
achievement
breast neoplasms
malignant neoplasm breast female
cancer screening
women
female mammary gland
early detection of cancer
national cancer institute (U.S.)

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/soutien-a-la-mise-en-oeuvre-dun-projet-pilote-sur-lusage-cible-des-medicaments-pour-le-traitement-de-lobesite-au-sein-de-centres-designes.html
2024
Canada
technical report
obesity
obesity, nos
drug therapy
substance-related disorders
pilot projects
health facilities
breast
methods
obesity
anti-obesity agents
central
drug, nos

---
https://ansm.sante.fr/tableau-marr/trastuzumab-deruxtecan
2024
false
false
false
France
French
risk management
trastuzumab deruxtecan
trastuzumab deruxtecan
infusions, intravenous
Antineoplastic Agents, Immunological
medication errors
guidelines for drug use
lung diseases
patient education handout
patients guideline
trastuzumab deruxtecan
Antineoplastic Agents, Immunological

---
https://www.has-sante.fr/jcms/p_3546684/fr/keytruda-pembrolizumab-carcinome-urothelial
2024
false
false
false
France
urologic neoplasms
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Enfortumab Vedotin/Pembrolizumab Regimen
enfortumab vedotin
adult
Metastatic Urothelial Carcinoma
Unresectable Urothelial Carcinoma
pembrolizumab
evaluation of the transparency committee
carcinoma
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3546934/fr/keytruda-pembrolizumab-cancer-du-rein-en-adjuvant
2024
false
false
false
France
Clear Cell Renal Cell Carcinoma
carcinoma, renal cell
treatment outcome
insurance, health, reimbursement
adult
Antineoplastic Agents, Immunological
pembrolizumab
Adjuvant Therapy
nephrectomy
risk
recurrence
evaluation of the transparency committee
pembrolizumab

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/indicateurs-de-la-qualite-des-soins-et-services-dispenses-au-sein-des-programmes-dimplantation-de-dispositifs-dassistance-ventriculaire-gauche-de-longue-duree.html
2024
Canada
handbooks
suggestive of
ventricle, nos
indication of
standard of care
devices
health personnel
left handedness
counseling
implant, nos
duration
heart-assist devices
Program
breast
device, nos

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024010/article/00001-fra.htm
2024
Canada
journal article
devices
blood pressure, nos
appraiser
equipment and supplies
adulthood
adult
arterial pressure
hypertension
automatism
device, nos
robot
measures
incidence
population
hypertensive disease, nos
automatism
Respect
Set, Psychology
weights and measures
breast

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1398
2024
France
public health guidelines
motivation
weights and measures
contraindication to
breast
screening
Contraindications
decreased motivation
virus, nos
european union
motivation, nos
donors
measures
waiting lists
transitory
seasons
tissue donors
west nile virus
albumin/globulin ratio
mass screening
research report

---
https://www.has-sante.fr/jcms/p_3556734/fr/mesmo
2024
France
health technology assessment
freezing
silicone
breast, nos
breast implants
anatomy
anatomist
round shape
Grassland
silicone gels
with texture
microscopy
implant, nos
anatomists

---
https://ansm.sante.fr/informations-de-securite/acetate-de-medroxyprogesterone-en-suspension-injectable-depo-prodasone-500-mg-risque-de-meningiome-et-mesures-de-reduction-du-risque
2024
false
false
false
France
French
risk management
meningioma
medroxyprogesterone acetate
injections, intramuscular
medroxyprogesterone
guidelines for drug use

---
https://dumas.ccsd.cnrs.fr/dumas-04635065
2024
France
dissertations, academic
pain, nos
osteopathic medicine
referral and consultation
bone diseases
child, nos
pain in children
disease of bone, nos
child
consultants
play
osteopathic physicians
Systematic Review
due to
play and playthings
pain management
breast
osteopath
classification

---
https://dumas.ccsd.cnrs.fr/dumas-04739090
2024
France
dissertations, academic
breast
evaluation studies as topic
fractures, bone
hospitals, university
fracture, nos

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024011/article/00001-fra.htm
2024
Canada
technical report
disease of breast, nos
population
breast cancer
sick days
breast diseases
cost of illness
malignant neoplasm breast female
female mammary gland
self care
patient care
sick leave
nursing
databases as topic
database
breast neoplasms
neoplasm staging
women
neoplasm, malignant

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/enquetes-etudes/2024/resultats-de-l-enquete-transversale-initiale-du-projet-13-en-sante-de-mediation-en-sante-aupres-des-populations-vulnerables-de-marseille.-conna
2024
France
technical report
viral disease other/nos
acquaintance
mediating
screening
health knowledge, attitudes, practice
health surveys
negotiating
vaccination, nos
detective
papillomavirus vaccines
Population Health
resulting in
posture, nos
colorectal neoplasms
transverse
vulnerable populations
insight, nos
breast
cross-sectional studies
vaccination
preventive immunization/medication
mass screening
vaccination
baseline survey

---
https://www.has-sante.fr/jcms/p_3552126/fr/allround
2024
France
health technology assessment
adhesion, nos
tissue adhesions
breast prosthesis
silicone
silicones
breast implants

---
https://www.has-sante.fr/jcms/p_3552129/fr/polysmooth-sublime-line
2024
France
health technology assessment
implant, nos
sublimation
silicone
breast, nos
freezing
breast implants
Grassland
silicone gels
Sublimation, Psychological
round shape

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024012/article/00001-fra.htm
2024
Canada
journal article
breast
population groups
anxiety disorder, nos
anxiety disorders
Indigenous Peoples

---
https://www.chu-lyon.fr/cancer-du-sein
2024
France
popular works
breast neoplasms
neoplasm, malignant
breast cancer

---
https://www.has-sante.fr/jcms/p_3443053/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
Unresectable HER2-Positive Breast Carcinoma
Metastatic HER2-Positive Breast Carcinoma
neoplasm metastasis
trastuzumab deruxtecan
guidelines for drug use
Antineoplastic Agents, Immunological
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
trastuzumab deruxtecan
Trastuzumab

---
https://publications.msss.gouv.qc.ca/msss/document-001121/
2024
false
false
false
Canada
patient education handout
mass screening
mammography
Medical Examination
Examination
Additional Information Report
screening mammography
screening
Review
Screening Mammography

---
https://ansm.sante.fr/tableau-acces-derogatoire/lynparza-100-mg-et-150-mg-comprimes-pellicules
2024
false
false
false
France
French
drug information
olaparib
administration, oral
olaparib
breast neoplasms
HER2-Negative Breast Carcinoma

---
https://ansm.sante.fr/tableau-acces-derogatoire/keytruda-25-mg-ml-solution-a-diluer-pour-perfusion#
2024
false
false
false
France
French
drug information
triple negative breast neoplasms
pembrolizumab
pembrolizumab
guidelines for drug use
adult
Early Stage Triple-Negative Breast Carcinoma
Locally Advanced Triple-Negative Breast Carcinoma
inflammatory breast neoplasms
Antineoplastic Agents, Immunological
endometrial neoplasms
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions
antineoplastic combined chemotherapy protocols
Enfortumab Vedotin/Pembrolizumab Regimen
Unresectable Urothelial Carcinoma
Metastatic Urothelial Carcinoma
urologic neoplasms
carcinoma

---
https://ansm.sante.fr/tableau-marr/atezolizumab
2024
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
drug information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal

---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2024
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/jcms/p_3488172/fr/lynparza-olaparib-cancer-de-l-ovaire
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
olaparib
antineoplastic combined chemotherapy protocols
Bevacizumab/Olaparib Regimen
adult
Carcinoma, Ovarian Epithelial
Stage III Ovarian Cancer AJCC v6 and v7
Stage IV Ovarian Cancer AJCC v6 and v7
fallopian tube neoplasms
peritoneal neoplasms
administration, oral
evaluation of the transparency committee
olaparib

---
https://www.has-sante.fr/jcms/p_3407319/fr/nagor-rgi
2023
France
health technology assessment
silicone
breast, nos
freezing
breast implants
round shape
Grassland
implant, nos
silicone gels

---
https://www.has-sante.fr/jcms/p_3407322/fr/cristalline-paragel
2023
France
health technology assessment
Grassland
crystallins
silicone gels
round shape
silicone
microscopy
lens, crystalline
implant, nos
breast, nos
with texture
freezing
breast implants

---
https://publications.msss.gouv.qc.ca/msss/document-003537/
2023
Canada
patient education handout
Breast Density
breast, nos
Specific gravity

---
https://www.has-sante.fr/jcms/p_3411344/fr/lynparza-olaparib-cancer-du-sein-precoce-a-haut-risque-her2-negatif
2023
false
false
false
France
Early Stage HER2-Negative Breast Carcinoma
HER2/Neu Negative
High Risk Breast Carcinoma
breast neoplasms
mutation
treatment outcome
insurance, health, reimbursement
Germline BRCA1 Gene Mutation
Germline BRCA2 Gene Mutation
administration, oral
olaparib
evaluation of the transparency committee
olaparib
breast neoplasms
risk

---
https://publication-theses.unistra.fr/public/theses_exercice/MED/2022/2022_LEISSNER_Pierre-Antoine.pdf
2023
France
dissertations, academic
inpatients
general practitioners
health services for the aged
internal medicine
general physician, nos
survivors
has patient
Geriatrics
COVID-19
breast
internal medicine specialist
mars
general practice
state medicine
hospital admission, nos
geriatric hospital
Hospitals, Rehabilitation
Periodical
rehabilitation hospital
geriatrics
Geriatrics
Physicians
aged
hospitals, university
subacute care

---
https://www.inspq.qc.ca/publications/3292
2023
Canada
technical report
breast cancer
screening for cancer
Program
controlled by
early detection of cancer
cancer screening
due to
receptors, proteinase-activated
Breast cancer
Benin
breast neoplasms
benin

---
https://apps.who.int/iris/handle/10665/365789
https://www.who.int/fr/publications-detail/9789240067134
2023
false
false
false
Switzerland
public health guidelines
french abstract
orientation
breast neoplasms
neoplasm, malignant
orientation, nos
Breast cancer
evaluation studies as topic
detective
patient care management
amplifiers, electronic
Reinforcement, Psychology
reinforcement, nos
breast cancer
early detection of cancer

---
https://www.has-sante.fr/jcms/p_3418105/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
sacituzumab govitecan
antineoplastic agents
Unresectable Hormone Receptor-Positive Breast Carcinoma
HER2-Negative Breast Carcinoma
adult
neoplasm metastasis
Metastatic Hormone Receptor-Positive Breast Carcinoma
evaluation of the transparency committee
breast neoplasms
sacituzumab govitecan

---
https://www.has-sante.fr/jcms/p_3395770/fr/keytruda-pembrolizumab-melanome-de-stade-iib-iic-ou-iii
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
adolescent
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIC Cutaneous Melanoma AJCC v6 and v7
melanoma
Stage III Cutaneous Melanoma AJCC v7
Advanced Cutaneous Melanoma
infusions, intravenous
Antineoplastic Agents, Immunological
evaluation of the transparency committee
melanoma
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3417612/fr/monobloc
2023
false
false
false
France
health technology assessment
breast, nos
breast implants
microscopy
Grassland
round shape
with texture
freezing
implant, nos
silicone
silicone gels

---
https://www.has-sante.fr/jcms/p_3417615/fr/monobloc
2023
false
false
false
France
health technology assessment
round shape
breast, nos
freezing
breast implants
silicone gels
silicone
Grassland
microscopy
with texture
implant, nos

---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma

---
https://www.cmg.fr/wp-content/uploads/2023/03/CMG-Retour-en-emploi-dans-le-cancer-du-sein.pdf
2023
France
scientific and technical information
breast cancer
return to work
employment
Employment
Breast cancer
unemployment
breast neoplasms
neoplasm, malignant

---
https://kce.fgov.be/fr/publications/tous-les-rapports/cancer-du-sein-les-cliniques-du-sein-agreees-font-elles-la-difference
2023
Belgium
technical report
french abstract
neoplasm, malignant
breast cancer
Breast cancer
breast neoplasms
hospitals, proprietary

---
https://www.has-sante.fr/jcms/p_3148278/fr/evaluation-de-la-performance-et-de-la-place-de-la-mammographie-par-tomosynthese-dans-le-programme-national-de-depistage-organise-du-cancer-du-sein-volet-2
2023
France
public health guidelines
cancer screening
mass screening
Organization
breast neoplasms
Breast cancer
mammography
screening mammography
breast cancer
program evaluation
screening for cancer
Organization
organization
early detection of cancer

---
https://www.has-sante.fr/jcms/p_3418553/fr/luna-xt
2023
France
health technology assessment
breast, nos
freezing
Grassland
anatomists
anatomist
Anatomy
breast implants
silicone
anatomy
silicone gels
with texture
implant, nos
microscopy
Anatomy

---
https://www.icn.ch/sites/default/files/2024-01/PS_Gender%20equity%20in%20the%20nursing%20and%20healthcare%20workforce%20%20FINAL%2012.2023_FR.pdf
2023
Switzerland
scientific and technical information
Murine Breast
Nurse
health personnel
Female Breast
Personal Attribute
On Staff
Health Equity
Fair
Male Breast
nursing staff
Research Personnel
breast

---
https://publication-theses.unistra.fr/public/theses_exercice/These_confidentielle.pdf
2023
France
dissertations, academic
breast cancer
First
breast neoplasms
Initial Usage
Use
Childhood Breast Carcinoma
Analysis
neoplasm, malignant
Person Initials
Analyzed
Initials
Initial Adverse Event and Product Problem Report
messenger
Male Breast Carcinoma

---
https://dumas.ccsd.cnrs.fr/dumas-04405466
2023
France
dissertations, academic
educational activities
Pharmaceutical Dosage Form
academic medical centers
education
central
Pharmaceutics
hospital, nos
Educational Activity
breast
Female Breast
gait, nos
Murine Breast
Male Breast
Usually Need Help from Another Person for Arising
Goes Out
hospitals, university
gait
Study Coordinating Center

---
https://ressources-aura.fr/wp-content/uploads/2024/01/BPA-PEC-2311MAST.pdf
2023
France
guideline
postoperative period
Period
Postoperative
mastectomy, nos
Post-Operative
Patient Load
Mastectomy Patient
mastectomy
Mastectomy
Clinical Trial Period
case management
has patient
exit
Patient Discharge
patient discharge

---
https://dumas.ccsd.cnrs.fr/dumas-04522088
2023
France
dissertations, academic
hospitals, university
Pharmacologic Substance
Placement
breast
academic medical centers
pharmaceutical preparations
central
Insertion
Going Well
GDC Therapeutic Agent Terminology
Insertion Mutation
drug, nos
Study Coordinating Center
Preparation
Male Breast
Medication
Murine Breast
Female Breast
hospital, nos
Insertion Mutation Abnormality

---
https://www.cancer.fr/catalogue-des-publications/brochure-reconstruction-mammaire-avec-illustration_inca-has
2023
false
false
false
France
patient education handout
malignant neoplasm breast female
mastectomy, nos
snacks
Breast cancer
breast neoplasms
women
female
mastectomy
female mammary gland
breast cancer
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3385847/fr/professionnels-decision-partagee-sur-la-reconstruction-mammaire
2023
France
scientific and technical information
handbooks
mammaplasty
operations research
mammoplasty, nos
Decision Making, Shared
caregivers

---
https://www.has-sante.fr/jcms/p_3424347/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2023
false
false
false
France
Metastatic HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Antineoplastic Agents, Immunological
receptor, erbB-2
treatment outcome
insurance, health, reimbursement
adult
trastuzumab deruxtecan
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3417618/fr/monobloc
2023
France
health technology assessment
breast, nos
implant, nos
silicone gels
breast implants
Grassland
freezing
round shape
silicone

---
https://www.has-sante.fr/jcms/p_3425643/fr/lynparza-olaparib-cancer-de-la-prostate
2023
false
false
false
France
antineoplastic combined chemotherapy protocols
treatment outcome
insurance, health, reimbursement
abiraterone
prednisone
prednisolone
neoplasm metastasis
adult
metastatic castration resistant prostate cancer
olaparib
antineoplastic agents
guidelines for drug use
administration, oral
evaluation of the transparency committee
olaparib
prostatic neoplasms

---
https://dumas.ccsd.cnrs.fr/dumas-04017328
2023
France
dissertations, academic
temperance
Developmental disorders
Developmental disorders
has patient
Overweight
Developmental disorder
intellectual disability
qualitative research
continuity of patient care
developmental disabilities
achievement
overweight
breast

---
https://www.euro-pharmat.com/les-publications/download/7770/5881/254
2023
France
journal article
hospitals, university
sterility, nos
prostheses and implants
medical devices
medical procedure, nos
implant, nos
hospital, nos
pharmacy service, hospital
Balance Sheet
breast
central
achievement
device, nos
Pharmacy
academic medical centers

---
https://www.cochrane.org/fr/CD010993/BREASTCA_la-mastectomie-avec-conservation-de-letui-cutane-est-elle-une-procedure-chirurgicale-efficace-et
2023
United Kingdom
review of literature
french abstract
Conservative Treatment
breast neoplasms
procedure, nos
breast cancer
procedures
neoplasm, malignant
Preserved food
mastectomy, nos
Breast cancer
mastectomy
skin, nos
mastectomy, segmental

---
https://www.cbip.be/fr/articles/4090?folia=4079
2023
false
false
false
Belgium
French
lactation disorders
journal article
pharmaceutical preparations
Drug-Related side effects and adverse reactions
breast feeding

---
https://www.has-sante.fr/jcms/p_3433922/fr/talzenna-talazoparib-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
talazoparib
talazoparib
Poly(ADP-ribose) Polymerase Inhibitors
metastatic castration resistant prostate cancer
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
evaluation of the transparency committee

---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/etudes-et-resultats/les-generalistes-plus-souvent-amenes-se
2023
France
journal article
general practitioners
coordination, nos
community
health
breast
residence characteristics

---
https://www.inspq.qc.ca/publications/3332
2023
Canada
technical report
quebec
facility regulation and control
facility control
research report
mammography, nos
quality control
albumin/globulin ratio
mammography

---
https://ansm.sante.fr/actualites/avis-de-lansm-du-13-04-2023-sur-le-medicament-talzenna-dans-le-cadre-dune-demande-daap
2023
false
false
false
France
French
drug information
administration, oral
talazoparib
talazoparib
Poly(ADP-ribose) Polymerase Inhibitors
adult
antineoplastic combined chemotherapy protocols
enzalutamide
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
metastatic castration resistant prostate cancer

---
https://ansm.sante.fr/tableau-acces-derogatoire/talazoparib-0-25-mg-gelule
2023
false
false
false
France
French
talazoparib
drug information

---
https://pap-pediatrie.fr/endocrinologie/gynecomastie-chez-lenfant-et-ladolescent
2023
France
algorithms
child, nos
adolescence
Adolescent
adolescent gynecomastia
Child
Gynecomasty
Child
child
Child
gynecomastia
Adolescent
gynecomastia
Child

---
https://www.cochrane.org/fr/CD012515/BREASTCA_formation-des-agents-de-sante-lexamen-des-seins-pour-la-detection-precoce-du-cancer-du-sein-dans-les
2023
United Kingdom
review of literature
french abstract
health education
asthenia
breast neoplasms
health
breast
detective
Breast cancer
breast cancer
early detection of cancer
examination of breast, nos
neoplasm, malignant
income

---
https://www.has-sante.fr/jcms/p_3444041/fr/verzenios-abemaciclib-cancer-du-sein-precoce-rh-/her2
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic agents
protein kinase inhibitors
abemaciclib
antineoplastic combined chemotherapy protocols
Adjuvant Therapy
Hormone Receptor-Positive Breast Carcinoma
hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive early breast cancer at high risk of recurrence
adult
evaluation of the transparency committee
abemaciclib
breast neoplasms

---
https://www.has-sante.fr/jcms/p_3444788/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2-faible
2023
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
trastuzumab deruxtecan
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
neoplasm metastasis
Metastatic HER2-Low Breast Carcinoma
adult
Unresectable Breast Carcinoma
HER2/Neu Low Expression
infusions, intravenous

---
https://www.cancer.fr/catalogue-des-publications/prevention-et-gestion-des-effets-indesirables-des-anticancereux-hormonotherapies-dans-le-traitement-adjuvant-des-cancers-du-sein
2023
false
false
false
France
guidelines for drug use
Antineoplastic agents
adjuvant, nos
antineoplastic agents
hormonotherapy
breast

---
https://www.has-sante.fr/jcms/p_3396878/fr/keytruda-pembrolizumab-cancer-du-sein-triple-negatif
2023
false
false
false
France
triple negative breast neoplasms
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
pembrolizumab
antineoplastic combined chemotherapy protocols
infusions, intravenous
Locally Advanced Triple-Negative Breast Carcinoma
Early Stage Triple-Negative Breast Carcinoma
locally advanced triple negative breast cancer at high risk of recurrence
early stage triple negative breast cancer at high risk of recurrence
evaluation of the transparency committee
pembrolizumab

---
https://www.has-sante.fr/jcms/p_3409403/fr/keytruda-pembrolizumab-carcinome-a-cellule-renale
2023
false
false
false
France
chemotherapy, adjuvant
treatment outcome
insurance, health, reimbursement
pembrolizumab
infusions, intravenous
Antineoplastic Agents, Immunological
clear cell renal cell carcinoma
nephrectomy
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell

---
https://www.has-sante.fr/jcms/p_3445734/fr/mentor
2023
France
health technology assessment
implant, nos
silicone gels
mentors
breast, nos
freezing
round shape
breast implants
silicone
Grassland

---
https://www.has-sante.fr/jcms/p_3445740/fr/monobloc
2023
France
health technology assessment
freezing
silicone gels
round shape
silicone
implant, nos
breast implants
breast, nos
with texture

---
https://www.has-sante.fr/jcms/p_3445743/fr/mentor-siltex
2023
France
health technology assessment
freezing
with texture
silicone gels
breast, nos
mentors
breast implants
silicone
Grassland
microscopy
round shape
implant, nos

---
https://www.has-sante.fr/jcms/p_3445746/fr/monobloc
2023
France
health technology assessment
implant, nos
breast implants
breast, nos
silicone
Grassland
round shape
with texture
freezing
silicone gels

---
https://www.has-sante.fr/jcms/p_3446069/fr/mentor-cpg
2023
France
health technology assessment
anatomist
microscopy
with texture
silicone gels
Anatomy
Anatomy
implant, nos
anatomists
freezing
Grassland
anatomy
breast implants
silicone
mentors
breast, nos

---
https://www.has-sante.fr/jcms/p_3447978/fr/ibrance-palbociclib-cancer-du-sein
2023
false
false
false
France
administration, oral
insurance, health, reimbursement
treatment outcome
tablets
Product containing only palbociclib in oral dose form (medicinal product form)
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
postmenopause
antineoplastic agents
evaluation of the transparency committee
palbociclib
breast neoplasms

---
https://www.yearbook-ers.jle.com/e-docs/synthese_pollution_atmospherique_et_risque_de_cancer_du_sein_dernieres_avancees_332389/yb_synthese.phtml
2023
France
journal article
breast neoplasms
Atmospheric pollution
pollution, nos
breast cancer
neoplasm, malignant
atmosphere
fracture fixation
air pollution
risk
Breast cancer

---
https://www.has-sante.fr/jcms/p_3447975/fr/enhertu-trastuzumab-deruxtecan-adenocarcinome-gastrique-ou-de-la-jonction-oesogastrique-jog
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
infusions, intravenous
stomach neoplasms
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
trastuzumab deruxtecan
insurance, health, reimbursement

---
https://www.has-sante.fr/jcms/p_3449668/fr/ergonomix-avec-qid
2023
France
health technology assessment
breast, nos
freezing
silicone
Grassland
round shape
silicone gels
implant, nos
breast implants

---
https://www.has-sante.fr/jcms/p_3449674/fr/round-silksurface-plus-avec-qid
2023
France
health technology assessment
silicone gels
round shape
implant, nos
silicone
breast implants
freezing
Grassland
breast, nos

---
https://www.has-sante.fr/jcms/p_3449677/fr/round-silksurface-plus-sans-qid
2023
France
health technology assessment
Grassland
round shape
breast, nos
freezing
silicone
silicone gels
breast implants
implant, nos

---
http://beh.santepubliquefrance.fr/beh/2023/14/2023_14_2.html
2023
France
journal article
Program
Organization
breast neoplasms
screening for cancer
France
Organization
organization
France
breast cancer
cancer screening
France
early detection of cancer
french
France
Breast cancer
mass screening
france

---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/etudes-et-resultats/mesures-environnementales-une-plus-grande
2023
France
journal article
households
social class
measures
weights and measures
Environment
breast
social environment
family characteristics

---
https://www.has-sante.fr/jcms/p_3455287/fr/trodelvy-sacituzumab-govitecan-cancer-du-sein
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
sacituzumab govitecan
sacituzumab govitecan
triple negative breast neoplasms
insurance, health, reimbursement
Unresectable Triple-Negative Breast Carcinoma
Metastatic Triple-Negative Breast Carcinoma
neoplasm metastasis
antineoplastic agents

---
https://www.santepubliquefrance.fr/regions/antilles/documents/enquetes-etudes/2023/evaluation-de-la-performance-du-programme-de-depistage-organise-du-cancer-du-sein-resultats-et-evolution-des-indicateurs-de-performance-dans-les
2023
France
technical report
indication of
breast neoplasms
suggestive of
Organization
screening for cancer
early detection of cancer
Outcome Assessment, Health Care
breast cancer
resulting in
cancer screening
Organization
organization
program evaluation
Breast cancer
mass screening
oceans and seas
outcome measures
Regions

---
https://anemf.org/wp-content/uploads/2023/06/Guide-de-lutte-contre-les-VSS.pdf
2023
France
handbooks
sex offenses
breast
Study Guide
Control
Physicians
Violencia
sexual violence
wrestling
Gender-Based Violence
medicine

---
https://www.cancer.fr/catalogue-des-publications/bande-dessinee-en-facile-a-lire-et-a-comprendre-falc-sur-le-depistage-des-cancers-du-sein-28-pages-a4
2023
false
false
false
France
patient education handout
screening
support, nos
instruction
mass screening
teaching
breast

---
https://www.has-sante.fr/jcms/p_3458293/fr/enhertu-trastuzumab-deruxtecan-cancer-de-l-estomac
2023
false
false
false
France
stomach neoplasms
adenocarcinoma
adult
treatment outcome
insurance, health, reimbursement
Locally Advanced Gastroesophageal Junction Adenocarcinoma
Refractory Gastroesophageal Junction Adenocarcinoma
Refractory Gastric Adenocarcinoma
Advanced Gastric Adenocarcinoma
Antineoplastic Agents, Immunological
trastuzumab deruxtecan
evaluation of the transparency committee
trastuzumab deruxtecan

---
http://docnum.univ-lorraine.fr/public/MED_T_2023_1096_A_ATTAR_BERTRAND_Clothilde.pdf
2023
France
dissertations, academic
physicians
Nominal Scale
Pool
Stage Grouping
general practitioners
insight, nos
disease
review literature as topic
Cognitive Disturbance
Pooled Blood Products
Chronic Graft Versus Host Disease
breast
Pooled Sample
aged
nursing
domicile
IRS Clinical Grouping System
Primary Care
weight-bearing
psychomotor agitation
Point
Neurocognitive Disorders
Male Breast
Agitation, CTCAE 3.0
primary health care
Point Name
age, nos
primary health care
Agitation
health planning guidelines
population groups
Murine Breast
Treating Physician
acquaintance
home care services
Female Breast
knowledge
Reviewing
Bedpans
medicine
Charge
agitation
principal
Subject Age
Pelvis
pelvis

---
https://dumas.ccsd.cnrs.fr/dumas-04132931
2023
France
dissertations, academic
education
Education
Family Practice
Male Breast
COVID-19 Infection
Female Breast
achievement
COVID-19
During or After
gestures
Regulatory Action
general practice
Murine Breast
Biomedicine
acquaintance
Evolution
Status Post
insight, nos
breast
Education Level
knowledge

---
https://publication-theses.unistra.fr/public/theses_exercice/MED/2023/2023_CAVALERIE_Marion.pdf
2023
France
dissertations, academic
Population Health
COVID-19 Infection
On Study
containment of biohazards
Biomedicine
community medicine
Off Study
physical and rehabilitation medicine
Pandemic Disorder
Male Breast
Mental Health
general practice
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
pandemics
mental health
Family Practice
Physical Well-being
Female Breast
Population Group
qualitative research
Socializing
Health Physics
psychiatry
Clinical Study
Murine Breast
COVID-19
Impact
breast
Healthcare Encounter
DICOM Study

---
https://www.cancer.fr/catalogue-des-publications/la-biopsie-chirurgicale-du-sein
https://www.cancer.fr/personnes-malades/les-cancers/sein/comprendre-les-cancers-du-sein/diagnostic/biopsie-chirurgicale-du-sein
2023
false
false
false
France
patient education handout
breast biopsy
biopsy, nos
Excisional Biopsy
biopsy
breast
Incisional Biopsy
Biopsy of Breast

---
https://www.cancer.fr/personnes-malades/les-cancers/sein/comprendre-les-cancers-du-sein/diagnostic/biopsie-percutanee-du-sein
https://www.cancer.fr/personnes-malades/diagnostic/examens/la-biopsie/biopsie-percutanee-du-sein
https://www.cancer.fr/catalogue-des-publications/la-biopsie-percutanee-du-sein
2023
false
false
false
France
patient education handout
breast
breast biopsy
Percutaneous Breast Biopsy
biopsy, nos
biopsy

---
Summary Safety Review - Keytruda (pembrolizumab) and Tecentriq (atezolizumab) - Assessing the Potential Risk of Aplastic Anemia
https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1691503886633
2023
false
false
false
Canada
French
drug evaluation
Drug-Related side effects and adverse reactions
pembrolizumab
antibodies, monoclonal, humanized
atezolizumab
Antineoplastic Agents, Immunological
risk assessment
anemia, aplastic
Immune Checkpoint Inhibitors
canada
pharmacovigilance note

---
https://www.cmg.fr/wp-content/uploads/2023/03/CMG-Retour-en-emploi-dans-le-cancer-du-sein.pdf
2023
France
scientific and technical information
breast neoplasms
Murine Back
Back
return to work
breast cancer
employment
Return
Childhood Breast Carcinoma
unemployment
Unemployed
Heart Sound Auscultation at Back
Male Breast Carcinoma
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3470396/fr/ibrance-palbociclib-cancer-du-sein
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
palbociclib
antineoplastic agents
protein kinase inhibitors
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
administration, oral
evaluation of the transparency committee
breast neoplasms
palbociclib

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-09-11-2023-arimidex-1-mg-comprime-pellicule
2023
false
false
false
France
French
drug information
Anastrozole
france

---
https://dumas.ccsd.cnrs.fr/dumas-04209970v1/
2023
France
dissertations, academic
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Management
No History of Myopathy
Chemotherapy Not Received
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Chief Complaint was Not Witnessed
Package
BRAF Mutation Analysis Was Not Performed
Program
Intercurrent Illness is Absent at Onset of Chief Complaint
Negation
Norway
EGFR Gene Amplification Negative
Unemployed
Any Metastatic Diagnosis Absent
Male Breast
Murine Breast
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
10q23/PTEN Locus Deletion Analysis Was Not Performed
Not Lost to Follow-Up
BRAF Rearrangement Analysis Was Not Performed
breast
Preoperative IV Antacids were not Administered
Patient was Not Previously Evaluated for Current Chief Complaint
Routine Cytogenetics Were not Completed
New Tumor Event After Initial Treatment Absent
IV Anesthesia was not Administered
Medication Not Taken
1p/19q Deletion Analysis Was Not Performed
Preoperative IV Opiates were not Administered
NF1 Mutation Analysis Was Not Performed
classification
Documentation Absent
Local Anesthesia Agents were not Administered
Radiation Therapy Not Received
Hypertension Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
Caffeine Not Routinely Consumed
On Study
IDH Family Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
review literature as topic
Evidence of Disease Absent after Completion of Therapy
Regular Smokeless Tobacco Use for Six Weeks or More Negative
non-occupational
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
No Known History of Illicit Drug Use
Management Occupations
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Gestational Complication
First Degree Family History of Primary Brain Tumor Negative
Regional Anesthesia was not Administered
No Response to Intervention for Kawasaki Disease
Radiation History Negative
No History of Rheumatic Fever
Additional Molecular Studies Were Not Performed
Tumor Progression Absent After Initial Treatment
Adjuvant Post-operative Chemotherapy Was Not Administered
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Chief Complaint Not Caused by Trauma
Tumor Reoccurrence Absent After Initial Treatment
Physician Diagnosed Diabetes Absent
Chemical/Occupational Exposure Absent
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
Additional Surgery for New Tumor Event Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No Known History of Alcohol Use
First Degree Family History Thyroid Cancer Negative
EGFR Amplification Analysis Was Not Performed
Reviewing
Adjuvant I-131 Therapy Negative
managed care programs
Preoperative IV Antiemetics were not Administered
NRAS Mutation Analysis Was Not Performed
IDH Family Wildtype
KRAS Mutation Analysis Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
PTEN Gene Mutation Negative
Care
ATRX Gene Mutation Negative
Paraneoplastic Syndrome is Not Present
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Use of Smokeless Tobacco at Time of Diagnosis Negative
Healthcare Activity
Cancer History Absent
Family History of Stomach Cancer Absent
PDGFRA Mutation Analysis Was Not Performed
home nursing
TP53 Mutation Analysis Was Not Performed
NON Mouse
MGMT Promoter Methylation Testing Was Not Performed
Other Preoperative IV Medications were not Administered
PTEN Mutation Analysis Was Not Performed
ALK Rearrangement Analysis Was Not Performed
History of Medical Treatment Absent
Neither Case or Control Status
Systematic Review
Intervention Not Given for Kawasaki Disease
New Disease is not Multifocal
Clinical Study Protocol
No History of Congenital Heart Disease
KIT Mutation Analysis Was Not Performed
Nitric Oxide Measurement
Additional Immunohistochemistry Was Not Performed
Patient was not Postmenopausal with no Prior Oophorectomy
How True Feel Carefree Right Now
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Has No Sibling
EGFR Mutation Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
History of Colorectal Cancer Negative
Lymph Node Dissection Was Not Performed
Preoperative IV Sedation was Not Administered
No History of Kawasaki Disease
Female Breast
Fluorescence In Situ Hybridization Was Not Performed
ATRX Mutation Analysis Was Not Performed
Nitric Oxide
No History of Neonatal Complication
Another Form of Birth Control was not Used
Minor Criteria for Rheumatic Heart Disease Not Present
RET Rearrangement Analysis Was Not Performed
Healthcare
MET Mutation Analysis Was Not Performed
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
First Degree Family History Cancer Negative
No History of Non-Cardiac Surgery
nursing
ERBB2 Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
SDH Complex Mutation Analysis Was Not Performed

---
https://dune.univ-angers.fr/fichiers/20112102/2023MCEM17347/fichier/17347F.pdf
2023
France
dissertations, academic
Bearing Device
Smoking Device
Male Breast
Medical Device
Murine Breast
devices
device, nos
Panel Device
general practitioners
equipment and supplies
General Qualifier
Counter Device
Female Breast
relief work
Set, Psychology
breast
Cup Device
Magazine Device

---
https://www.has-sante.fr/jcms/p_3471037/fr/actualisation-2023-utilite-clinique-des-signatures-genomiques-dans-le-cancer-du-sein-rh-/her2-de-stade-precoce
2023
France
health technology assessment
neoplasm staging
Clinical Batch
Medical Examination
early
genome
breast cancer
Clinical Lot
technology assessment
genomics
Early Stage Breast Carcinoma
Genome
Clinical Data
hospitals, proprietary
health
Ambulatory Care Facility
Technology Assessment
neoplasm, malignant
genome, nos
technology assessment, biomedical
breast neoplasms
Signature
Useful

---
https://sante.gouv.fr/IMG/pdf/2023_07_18_doc_d_aide_au_signalement_des_ps_vf.pdf
2023
France
technical report
Document
spouse abuse
couples
Health Professional
Atherogenic Index of Plasma
Without Help
With Some Help
Acute Interstitial Pneumonia
breast
Assistance
Document
health
Violence
caregivers
AIP Gene
violence
Female Breast
cues
Single-Stranded DNA Cytosine Deaminase
AH Receptor-Interacting Protein
Couple
AICDA wt Allele
Reporting
paper
Male Breast
Murine Breast

---
https://www.inspq.qc.ca/publications/3387
2023
Canada
technical report
breast neoplasms
Program
screening for cancer
Lansky Performance Status 20
Breast Cancer Screening
Autonomic Nervous System
Karnofsky Performance Status 20
Sample Statistic
statistics
cancer screening
Twenty
Experiment Object
breast cancer
Schedule
Andorra
Scheduled
statistics as topic
Statistics
early detection of cancer

---
https://www.has-sante.fr/jcms/p_3404153/fr/kisqali-ribociclib-cancer-du-sein
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
antineoplastic agents
protein kinase inhibitors
ribociclib
antineoplastic combined chemotherapy protocols
Letrozole
Letrozole/Ribociclib Regimen
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
neoplasm metastasis
evaluation of the transparency committee
breast cancer
ribociclib
breast neoplasms

---
https://www.has-sante.fr/jcms/p_3406124/fr/tecentriq-atezolizumab-cancer-bronchique-non-a-petites-cellules-cbnpc
2023
false
false
false
France
evaluation of the transparency committee
Tecentriq
neoplasm, malignant
"u" lymphocyte
cancer
atezolizumab
due to
Cancer
atezolizumab
bronchus, nos
Cell
carcinoma, non-small-cell lung
cells

---
https://ansm.sante.fr/actualites/lansm-publie-de-nouvelles-donnees-sur-la-surveillance-des-implants-mammaires
2023
false
false
false
France
French
product surveillance, postmarketing
scientific and technical information
breast implants
france

---
https://minerva-ebp.be/FR/Article/2302
2023
Belgium
critical appraisal or critical reading
hormone, nos
breast neoplasms
menopause
hormonotherapy
hysterectomy, nos
breast cancer
female
temefos
estrogen replacement therapy
women
hysterectomy
health planning guidelines
menopause, nos
neoplasm, malignant
hormones
associated with
Breast cancer
snacks
systolic pressure
incidence

---
https://www.has-sante.fr/jcms/p_3407313/fr/impleo-smooth
2023
France
health technology assessment
breast implants
round shape
implant, nos
silicone gels
Grassland
freezing
breast, nos
silicone

---
https://www.has-sante.fr/jcms/p_3407316/fr/paragel
2023
France
health technology assessment
breast, nos
silicone
round shape
silicone gels
freezing
breast implants
Grassland
implant, nos

---
https://dumas.ccsd.cnrs.fr/dumas-04008781
2022
France
dissertations, academic
malignant neoplasm breast female
screening for cancer
midwifery
breast cancer
female mammary gland
cancer screening
midwives
diagnostic self evaluation
Breast cancer
Practice
Self-Evaluation
early detection of cancer
breast neoplasms

---
https://dumas.ccsd.cnrs.fr/dumas-04056790
2022
France
dissertations, academic
Organization
General studies
Language
organizers, embryonic
Learning
breast
General studies
general practitioners
Organization
language therapy
General studies
basic learning problem in language
General studies
Learning
Physicians
language training
organizations
General studies
organization
General studies
Learning Disabilities
community health centers
General studies
Language
health
feasibility studies

---
https://www.theses.fr/2022UCFAC048
2022
France
neoplasm, malignant
Biology
breast neoplasms
hospitals, proprietary
disease
has patient
Breast cancer
biology
breast cancer
case management
biology

---
https://www.yearbook-ers.jle.com/e-docs/exposition_aux_perturbateurs_endocriniens_et_risque_de_cancer_du_sein_une_revue_systematique_332407/yb_breve.phtml
2022
France
journal article
breast cancer
Taxonomy
Exhibition
neoplasm, malignant
Systematics
effects of exposure to external cause, nos
endocrine gland neoplasms
classification
Systematics
risk
Systematics
endocrine gland, nos
breast neoplasms
Breast cancer
Systematic Review
endocrine disruptors

---
https://cngof.fr/app/pdf/RPC//1-RPC%20DU%20CNGOF/2022-2023/RPC-Mastectomies-reduction%20de%20risque-Indications-2022.pdf
2022
France
practice guideline
Gynecologists
indicators and reagents
gynecologist
obstetrician
suggestive of
Genetic Susceptibility
risk reduction
French Language
French Catheter Gauge
Obstetricians
french
health planning guidelines
Risk Reduction
genetic predisposition to disease
Mastectomy Patient
risk reduction behavior
france
mastectomy, nos
Mastectomy
mastectomy
College Completion
indication of
schools

---
https://cngof.fr/app/pdf/RPC//1-RPC%20DU%20CNGOF/2022-2023/RPC-Mastectomies-reduction-risque-Modalits%20morbit%202022.pdf
2022
France
practice guideline
risk reduction behavior
health planning guidelines
mastectomy
College Completion
French Catheter Gauge
Risk Reduction
Genetic Susceptibility
Mastectomy
risk reduction
mastectomy, nos
obstetrician
schools
Mastectomy Patient
genetic predisposition to disease
france
Obstetricians
gynecologist
morbidity
french
Gynecologists
French Language

---
https://dumas.ccsd.cnrs.fr/dumas-04176781
2022
France
dissertations, academic
emergencies
Murine Breast
Male Breast
Artificial Intelligence
traumatology
Emergency Room
Emergency
artificial intelligence
Urgency
intelligence, nos
Female Breast
breast

---
https://dumas.ccsd.cnrs.fr/dumas-04272767
2022
France
dissertations, academic
NCI Thesaurus Role
hospital, nos
AICDA wt Allele
pharmacist
computerized physician order entry system
hospitals, university
Study Coordinating Center
Acute Interstitial Pneumonia
Murine Breast
Computer Program
Global Change/UV
AH Receptor-Interacting Protein
Role Entity
role
academic medical centers
Security Role Object
change of prescription, nos
Male Breast
AIP Gene
medical records systems, computerized
Atherogenic Index of Plasma
informatics
Without Help
has patient
pharmacists
Assistance
Delta
software
Female Breast
Social Role
Single-Stranded DNA Cytosine Deaminase
Electronic Medical Record
Prescription
central
breast
With Some Help

---
https://publications.msss.gouv.qc.ca/msss/document-003431/
2022
Canada
handbooks
mammography, nos
hospitals, proprietary
women
mammography

---
https://www.ema.europa.eu/en/medicines/human/EPAR/zolsketil-pegylated-liposomal
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
doxorubicin
doxorubicin
doxorubicin
antibiotics, antineoplastic
antibiotics, antineoplastic
liposomal doxorubicin
liposomal doxorubicin
Pegylated Liposomal Doxorubicin Hydrochloride
drug approval
europe
adult
breast neoplasms
Metastatic Breast Carcinoma
neoplasm metastasis
ovarian neoplasms
Advanced Ovarian Carcinoma
Platinum-Refractory Ovarian Carcinoma
multiple myeloma
sarcoma, kaposi
AIDS-related kaposi sarcoma
aids-related opportunistic infections
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
antineoplastic combined chemotherapy protocols
Bevacizumab/Liposomal Doxorubicin Regimen

---
https://www.has-sante.fr/jcms/p_3351493/fr/amoena-balance-adapt-air
2022
France
health technology assessment
radiographic image enhancement
Air
Techniques
breast implants
habilitation
silicone
air
Techniques
rehabilitation
air, nos
silicones
breast prosthesis
incomplete
Techniques
tissue adhesions
adaptation, nos
Techniques
adhesion, nos

---
https://www.has-sante.fr/jcms/p_3357271/fr/velvety-softlite
2022
France
health technology assessment
Techniques
adhesion, nos
silicone
breast prosthesis
breast implants
Techniques
tissue adhesions
silicones
Techniques
Techniques

---
https://www.has-sante.fr/jcms/p_3357629/fr/monobloc
2022
France
health technology assessment
Grassland
silicone gels
implant, nos
freezing
silicone
round shape
breast, nos
breast implants

---
https://www.has-sante.fr/jcms/p_3358124/fr/infracyanine-vert-d-indocyanine-monopic-reperage-peroperatoire-du-ganglion-sentinelle
2022
false
false
false
France
coloring agents
insurance, health, reimbursement
diagnostic uses of chemicals
intraoperative period
indocyanine green
breast neoplasms
lymphatic system
evaluation of the transparency committee
Sentinel Lymph Node
indocyanine green

---
https://www.has-sante.fr/jcms/p_3359071/fr/verzenios-abemaciclib-cancer-du-sein
https://www.has-sante.fr/jcms/p_3359075/fr/decision-n2022-0245/dc/sem-du-13-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-refus-de-la-demande-d-acces-precoce-de-la-specialite-verzenios
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
antineoplastic agents
protein kinase inhibitors
abemaciclib
antineoplastic combined chemotherapy protocols
hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive early breast cancer at high risk of recurrence
evaluation of the transparency committee
abemaciclib
breast neoplasms

---
https://www.inspq.qc.ca/publications/2874
2022
false
false
false
Canada
COVID-19
technical report
cancer screening
Breast cancer
pandemics
early detection of cancer
Program
screening for cancer
breast cancer
breast neoplasms

---
https://www.has-sante.fr/jcms/p_3359829/fr/enhertu-trastuzumab-deruxtecan-cancer-estomac
2022
false
false
false
France
Antineoplastic Agents, Immunological
trastuzumab deruxtecan
antibodies, monoclonal, humanized
immunoconjugates
camptothecin
insurance, health, reimbursement
treatment outcome
stomach neoplasms
adenocarcinoma
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
esophagogastric junction
HER2/Neu Positive
HER2 positive gastric cancer
adult
infusions, intravenous
evaluation of the transparency committee
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3362636/fr/natrelle-et-brst
2022
France
health technology assessment
Grassland
freezing
implant, nos
silicone gels
silicone
breast, nos
breast implants

---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/rapports/suicide-mesurer-limpact-de-la-crise-sanitaire-liee-au-0
2022
false
false
false
France
French
technical report
suicide
COVID-19
research report
crisis, nos
population
measures
Suicide
breast
albumin/globulin ratio
pain
adolescent
Suicide
suicide, nos
Suicide
weights and measures

---
https://dumas.ccsd.cnrs.fr/dumas-03765337
2022
France
dissertations, academic
couples
Animal
pets
Animals
panthera uncia
Animals
Animals
france
Animals
Animal
Animal
heterosexuals
family characteristics
France
France
heterosexuality
France
Animals
France
animal, nos
breast
french

---
https://n2t.net/ark:/47881/m6513z1s
2022
France
dissertations, academic
body weight
birthing centers
containment of biohazards
achievement
motherhood
breast
hospices
historical cohort studies
cohort studies

---
https://www.vie-publique.fr/rapport/286331-etude-nationale-sur-les-morts-violentes-au-sein-du-couple-2021
2022
France
technical report
data collection
breast
family characteristics
couples

---
https://www.has-sante.fr/jcms/p_3367810/fr/keytruda-pembrolizumab-cancer-du-col-de-l-uterus
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
uterine cervical neoplasms
Antineoplastic Agents, Immunological
pembrolizumab
pembrolizumab
infusions, intravenous
adult
antineoplastic combined chemotherapy protocols
package leaflet
summary of product characteristics
guidelines for drug use
neoplasm recurrence, local
neoplasm metastasis
PD-L1 Positive
evaluation of the transparency committee

---
https://curie.fr/dossier-pedagogique/les-recidives-du-cancer-du-sein
2022
France
popular works
breast cancer
breast neoplasms
Breast cancer
neoplasm, malignant
recurrence

---
https://www.has-sante.fr/jcms/p_3373582/fr/zolsketil-pegylated-liposomal-chlorhydrate-de-doxorubicine
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
Pegylated Liposomal Doxorubicin Hydrochloride
breast neoplasms
neoplasm metastasis
ovarian neoplasms
Advanced Ovarian Carcinoma
Platinum-Refractory Ovarian Carcinoma
Metastatic Breast Carcinoma
AIDS-related kaposi sarcoma
doxorubicin
antibiotics, antineoplastic
evaluation of the transparency committee
doxorubicin
liposomal doxorubicin

---
https://www.has-sante.fr/jcms/p_3368269/fr/verzenios-abemaciclib-traitement-adjuvant-du-cancer-du-sein-precoce-avec-rh-positifs
2022
false
false
false
France
treatment outcome
breast neoplasms
antineoplastic combined chemotherapy protocols
Early Stage Breast Carcinoma
chemotherapy, adjuvant
Hormone Receptor-Positive Breast Carcinoma
administration, oral
abemaciclib
antineoplastic agents
protein kinase inhibitors
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
HER2-Negative Breast Carcinoma
evaluation of the transparency committee
abemaciclib

---
https://www.gustaveroussy.fr/sites/default/files/referentiel-senorif-2021-2022.pdf
2022
false
false
false
France
breast neoplasms
breast neoplasms
breast neoplasms
genetic predisposition to disease
women's health
mass screening
breast neoplasms
breast neoplasms
carcinoma, ductal
breast neoplasms
antineoplastic protocols
antineoplastic agents, hormonal
breast neoplasms
radiotherapy
algorithms
neoplasm staging
COVID-19
quality of life
female
guideline
clinical protocols

---
https://www.has-sante.fr/jcms/p_3383475/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2-faible
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Antineoplastic Agents, Immunological
receptor, erbB-2
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm metastasis
Unresectable
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
Trastuzumab
breast neoplasms
trastuzumab deruxtecan

---
https://www.cancer.fr/catalogue-des-publications/traitements-locoregionaux-des-cancers-du-sein-infiltrants-non-metastatiques-thesaurus-partie-1
2022
false
false
false
France
practice guideline
breast
non-infiltrating
injections, Intra-Articular

---
https://archive.bu.univ-nantes.fr/pollux/show/show?id=2e18c0ce-9b42-4315-a037-934307b3df98
2022
France
dissertations, academic
sexuality
breast
fireplace
focal
sexual state, nos

---
https://dumas.ccsd.cnrs.fr/dumas-03819637
2022
France
dissertations, academic
academic medical centers
hospitals, university
best practices
Practice
Preparation
hospital, nos
breast
central

---
https://dumas.ccsd.cnrs.fr/dumas-03829458
2022
France
dissertations, academic
Fracture
case management
Orthopedic surgery
femoral fractures
containment of biohazards
orthopedic surgery
breast
fracture: femur
hospital admission, nos
hip fractures
orthopedics
operative procedure, nos
Surgery
COVID-19
fracture of femur, nos
aged
pandemics
has patient
inpatients

---
https://www.santepubliquefrance.fr/content/download/487321/3685364
2022
France
technical report
saints
snacks
research report
Researches
thyroid diseases
Pathology
population groups
Pathology
breast diseases
Pathology
Pathology
albumin/globulin ratio
Pathology
Disorders
Pathology
investigative report
laboratory research
Pathology
Breast disease

---
https://www.has-sante.fr/jcms/p_3390617/fr/tecentriq-atezolizumab-cancer-du-poumon
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
recurrence
carcinoma, non-small-cell lung
antineoplastic agents
infusions, intravenous
atezolizumab
Adjuvant Therapy
evaluation of the transparency committee
atezolizumab

---
https://www.has-sante.fr/jcms/p_3390429/fr/keytruda-pembrolizumab-cancer-du-sein
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
pembrolizumab
evaluation of the transparency committee
triple negative breast neoplasms
pembrolizumab

---
https://dumas.ccsd.cnrs.fr/dumas-03643111/
2022
France
dissertations, academic
COVID-19
emergency medicine
emergency service, hospital
prevalence studies
hospitalists
Physicians
hospitals
hospital, nos
vaccination, nos
hospital medicine
breast
emergicenters
central
cross-sectional studies
SARS-CoV-2
first aid
immunization

---
https://dune.univ-angers.fr/fichiers/17012107/2022MCEM16071/fichier/16071F.pdf
2022
France
dissertations, academic
principal
general practitioners
consultants
Physicians
primary prevention
preventive medicine
breast

---
https://ged.univ-rennes1.fr/nuxeo/site/esupversions/d0e2b801-ad55-4124-86d1-3ccdce922032
2022
France
dissertations, academic
Data Systems
french
pandemics
delivery of health care
France
france
France
France
health
breast
COVID-19
confidentiality
France

---
https://www.has-sante.fr/jcms/p_3374922/fr/keytruda-pembrolizumab-cancer-du-col-de-l-uterus
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
pembrolizumab
infusions, intravenous
Antineoplastic Agents, Immunological
adult
neoplasm metastasis
neoplasm recurrence, local
antineoplastic combined chemotherapy protocols
evaluation of the transparency committee
uterine cervical neoplasms
pembrolizumab
cancer of the uterine cervix

---
https://www.unisante.ch/fr/formation-recherche/recherche/publications/raisons-sante/raisons-sante-341
2022
Switzerland
technical report
early detection of cancer
Epidemiologists
program evaluation
breast cancer
cancer screening
Epidemiology
epidemiology
Breast cancer
breast neoplasms
Epidemiology
Epidemiology
Epidemiology
Epidemiology
screening for cancer

---
https://www.fhf.fr/expertises/ressources-humaines/personnel-non-medical/les-ambulanciers-sont-integres-au-sein-de-la-filiere-soignante-de-la-fph
https://www.legifrance.gouv.fr/eli/decret/2022/12/26/SPRH2233900D/jo/texte
2022
false
false
false
France
legislation
breast
has provider
caregivers

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-risques-hospitalisation-vaccin-covid-19-outre-mer
2022
France
technical report
COVID-19
Vaccinia
risk assessment
vaccination
Vaccins
oceans and seas
risk
breast
COVID-19 Vaccines
vaccination
preventive immunization/medication
vaccination, nos
appraiser

---
https://www.calameo.com/onco-occitanie/read/007178092b764f5a7f40b
2022
France
guideline
breast
ovary

---
https://theses.hal.science/tel-03934854
2022
France
dissertations, academic
environmental neoplasms
has patient
breast neoplasms
Environment
reimplantation, nos
patients
social environment
breast cancer
neoplasm, malignant
occupational neoplasms
Breast cancer
rehabilitation

---
https://www.theses.fr/2022SORUS358
2022
France
dissertations, academic
breast neoplasms
Breast cancer
rehabilitation
environmental neoplasms
has patient
patients
social environment
breast cancer
reimplantation, nos
Environment
neoplasm, malignant
occupational neoplasms

---
Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.